The American Academy of Dermatology estimates 80 million Americans suffer from hair loss.  But a potential cure for baldness is getting nearer as scientists have successfully grown “unlimited” hair on mice using stem cells and are now refining the process to be used on humans.

Stemson Therapeutics recently announced a major advance for its proprietary hair rejuvenation solution, which will allow science to advance toward human hair restoration clinical trials.   Stemson is developing an iPSC-derived autologous cell therapy to regenerate healthy hair follicles and has successfully created human hair follicles in humanized mice using engineered follicular units (EFUs).  These engineered follicular units will be the first therapeutic solution capable of replacing lost hair follicles – a huge scientific technological breakthrough.

The Stemson team of scientists, along with Senior Medical Advisor Dr. Paul McAndrews, are passionate about creating this scientifically based clinically tested cure for hair loss to the millions of sufferers who seek expert help for their medical condition.

As of today, there are only a few medically proven treatments to prevent hair loss, and the first effective treatment is finding the cause.  To get an accurate medical diagnosis, see a board-certified Dermatologist who has in-depth knowledge about the many causes of hair loss and experience treating the diverse medical conditions.

Dr. McAndrews is a board-certified Dermatologist hair transplant surgeon, formally trained with FUT and FUE hair transplants, currently teaching USC’s medical residents the latest scientific advances in both the medical and surgical treatments of hair restoration, and a leading expert in the hair transplant medical world.